Lv2
140 积分 2024-05-09 加入
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
6小时前
待确认
中华医学会肺癌临床诊疗指南（2024版）
12小时前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
1个月前
已完结
中国去势抵抗性前列腺癌诊治专家共识
1个月前
已完结
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer
3个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4个月前
已完结
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
6个月前
已完结
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
6个月前
已完结
皖公网安备34019202002308
